Aim
This study compared the efficacy of FRS, UKPDS, JALS-ECC, max-IMT and their combinations in predicting CAS as detected on CCTA in asymptomaticpatientswithtype2diabetes.
Methods

Subjects
Weretrospectivelyanalyzedtheobtaineddatafor patientswithtype2diabeteswhohadbeenadmitted forthetreatmentofdiabetesandunderwentCCTAat the University of Tsukuba Hospital between April 2009andMarch2012.Duetocomplicationsassociated with CCTA, such as renal failure, allergies and radiation-related issues, we reserved this modality for thoseathighriskforCADinwhomtherisk/benefit ratioindicateditsuse.ReasonsforperformingCCTA includedamax-IMTof≥ 1.1mm,ischemicchanges onanelectrocardiogram(ECG),positiveexerciseECG testresultsorleftventricularwallmotionabnormalitiesonechocardiography.Inmosthealthyindividuals, the max-IMT has been reported to not exceed 1.1 mminJapan 17) .ECGabnormalities,suchasQwaves, ST-TchangesandnegativeTwaves,positiveexercise ECG test results and left ventricular wall motion abnormalitiesonechocardiographywereconsideredto besuggestiveofthepresenceofCAD.Theexclusion criteria included chest symptoms, known CAD, type 1diabetesmellitus,aserumtriglyceride(TG)levelof ≥ 4.5mmol/Landventricularorsupraventriculararrhythmias.Allpatientsunderwentastructuredinterview,physical examination and laboratory analysis.The 10-year riskofcoronaryheartdiseasewascalculatedaccording to the FRS and UKPDS 7, 8) . Based on the risk score determined according to the JALS-ECC 9) , the 5-year risk of acute MI was calculated. The subjects were then divided into tertiles for each risk score. Hypertensionwasdefinedasasystolicbloodpressure(SBP) of ≥ 140 mmHg and/or diastolic blood pressure (DBP)of≥ 90mmHgorthecurrentuseofantihyper-tensiveagents.Diabeticretinopathywasdiagnosedby ophthalmologists. A urinary microalbumin excretion of ≥ 30 mg/day indicated diabetic nephropathy.The glomerularfiltrationratewasestimatedusinganequationmodifiedfortheJapanese,aspreviouslydescribed 18) . Diabeticneuropathywasdefinedasareducedbilateral ankle vibrationsensation (＜10 s), reduced or absent bilateralAchillestendonreflexesand/orimpairmentof lighttouch;othercausesofneuropathywereexcluded. ThisstudywasapprovedbytheEthicsCommitteeof the University of Tsukuba Hospital and conducted
Introduction
Type2diabetesmellitusisastrongriskfactorfor coronary artery disease (CAD), and diabetic patients withoutahistoryofpriormyocardialinfarction(MI) havethesameriskofCADdeathasnon-diabeticindividualswithahistoryofpriorMI 1) .Identifyingpatients at risk of developing CAD events is one of the most challengingissuesinclinicalpractice,especiallyinpatients withtype2diabetes.Coronarycomputedtomography angiography (CCTA) has been proposed to be an alternativeimagingmodalitytocoronaryangiography for evaluating patients with known or suspected CAD [2] [3] [4] [5] [6] .TheapplicationofCCTA,however,hastraditionally been limited to patients with a high CAD riskduetoexposuretocontrastmediaandradiation.
Risk assessment tools have been proposed to assesstheriskoffutureCAD.Amongthem,theFraminghamRiskScore(FRS) 7) andUKProspectiveDiabetes Study (UKPDS) risk engine 8) are the most frequently used. Recently, a coronary events prediction model specific to the Japanese population was established based on the Japan Arteriosclerosis Longitudinal Study-Existing Cohorts Combine (JALS-ECC) 9) . Althoughriskscoresareusuallyutilizedtopredictfuture cardiovascularevents,itisunclearwhethertheycanbe usedtopredictthecurrentcoronaryarteryatherosclerosis burden and near-future events. Moreover, traditionalCADriskfactorsfailtopredictthedevelopment ofCADinalargenumberofcases(25%to50%) 10, 11) . Measurementsofthecarotidintima-mediathickness (IMT) are used in epidemiologic and intervention studies as a surrogate marker of atherosclerosis. Weandothergroupshaveshownthatthemaximum-IMT(max-IMT)canbeusedtopredicttheonsetof coronary artery stenosis (CAS) in asymptomatic patientswithtype2diabetes [12] [13] [14] .Moreover,themax-IMT has a threshold for predicting CAS 14) . Recent studies have demonstrated that the combination of risk scores and carotid IMT improves the prediction of cardiovascular disease 15, 16) . We therefore hypothesized that the use of carotid IMT measurements in high-risk patients would help to effectively identify those at risk for CAS.We also hypothesized that the combinationofariskscoreandthemax-IMTwould bebetterinpredictingCASthantheriskscorealone.
ThemeanIMTwasmeasuredforbothCCAs,excluding the bulbus, and defined as the average of three points that included the point of the max-IMT and two points on either side (each point 1 cm distant from the point of the max-IMT) 17) . Plaque was definedasthepresenceoffocalwallthickeningatleast 50% greater than that of the surrounding vessel wall orafocalregionwithanIMTof＞1.1mmprotrud-ing into the lumen and distinct from the adjacent boundary.The number of plaques was counted from thedistal10mmoftheCCAtotheproximalinternal carotid artery. The degree of stenosis of the internal carotidarterywascalculatedaccordingtothefollowingformula:percentminimallumendiameterdivided bytheadventitialdiametermeasuredatthesameposition.Theintra-andinter-dayandinterobservervariabilityoftheIMTwas3.0±3.0%,2.7±3.7%and6.8
±2.4%,respectively,inmeasuring20consecutiveIMTs.
Statistical Analysis
Categorical variables were expressed as numbers and percentages and compared using Fisher's exact test.Continuousvariableswereexpressedasthemean ±SDormedianandinterquartilerange(IQR).Based on distribution, continuous variables were compared usingunpairedStudent'st-testortheMann-Whitney U-test for two-group comparisons. The odds ratio (OR) and 95% confidence interval (CI) were estimated using a logistic regression analysis of each risk scoreandmax-IMTcategory,withthelowesttertileas thereference.Trendsthroughtertilesofeachriskscore wereanalyzedusingageneralizedlinearmodel.Moreover,theincidenceofCASwithrespecttothedifferentmax-IMTcategories(tertile1vs.tertile2or3)for eachriskscorewascomparedusingFisher'sexacttest. Theabilityofeachriskscore,max-IMTorcombination of these factors to predict CAS was examined using receiver operating characteristic (ROC) curve analyses. The areas under the ROC curves (AUCs) were calculated for the detection of CAS. We also determined the net reclassification improvement (NRI) using three risk categories (0-＜30%, 30-＜ 60% and ≥ 60%) and the integrated discrimination improvement(IDI) 20) .Allstatisticalanalyseswereperformed using the SPSS software program (version 15.0; Chicago, IL, USA). Statistical significance and borderlinesignificanceweredefinedasP＜0.05andP ＜0.10,respectively.
Results
Characteristics of the Subjects
A total of 139 patients were enrolled. TwentyaccordingtotheDeclarationofHelsinki.
Laboratory Analysis
Blood samples were collected the morning after an overnight fast. The plasma glucose, serum total cholesterol, high-density lipoprotein-cholesterol (HDL-C),TG and creatinine levels were determined using an automated analyzer (7700 clinical analyzer; Hitachi High-Technologies Corporation, Tokyo, Japan).Theserumlow-densitylipoprotein-cholesterol (LDL-C)levelswerecalculatedaccordingtotheFriedewald equation when the plasmaTG concentration did not exceed 4.5 mmol/L. The HbA1c level was measured using high-performance liquid chromatography (HLC-723G9; Tosoh Corporation, Tokyo, Japan) and converted from the Japanese Diabetes Society value into the National Glycohemoglobin StandardizationProgram(NGSP)equivalentvalue 19) .
CCTA
The degree of coronary stenosis was assessed usingaPhilipsBrilliance-64scanner(PhilipsMedical Systems,Cleveland,OH,USA)witha64×0.625-mm detectorconfiguration.Scanningwasperformedat120 kV,600-1,050mAand0.2pitchwithstandardorsharp filters.Atotalof60mLofcontrastagent(iopamidol: 370mg/mL;Schering,Berlin,Germany)wasinjected i.v.atarateof4ml/s.Whenthesignaldensityinthe ascendingaortareachedapredefinedthresholdof100 Hounsfield units, the acquisition of CT data and an ECG trace were automatically started during 7 to 9 seconds of breath-holding. Patients with a heart rate of＞70beats/minweregivenoralmetoprolol(20mg) onehourbeforetheexaminations.Thescanswereanalyzed using a Brilliance Workspace 3-D workstation (Philips Medical Systems). Each scan was analyzed independentlybytwoexperiencedreadersunawareof thepatient'sidentityorclinicalpresentation.Luminal narrowingof≥ 50%onCCTAindicatedCAS.
Carotid Ultrasonography
B-modeexaminationsofthecarotidarterieswere performed on an ultrasound system with a 7.5/10-MHz linear array transducer. Scanning of each commoncarotidartery(CCA)beganjustabovetheclavicle and then passed cephalically through the bifurcation as far distally as possible.The carotid IMT was determined based on the distance from the leading edge of the lumen-intima interface of the far wall to theleadingedgeofthemedia-adventitiainterface.The max-IMT was determined as the greatest thickness measuredonbothsidesoftheCCA,bulbusandinternalcarotidartery,excludingtheexternalcarotidartery. (21) 6 (13) 14(29) 11 (23) 13 (27) 7 (15) 1 (2) 2(4) 0.9(0.7-1.2) 1.6(1.2-2.6) 7.6±0.7 5.9±0.6 23±5 2.6±1. (31) 14 (21) 34 (50) 31 (46) 43 (63) 
Thedataarepresentedasthen(%),mean±SDormedian(interquartilerange).ACEI,angiotensin-convertingenzymeinhibitor;ARB,angiotensin
Ⅱreceptorblocker;BMI,bodymassindex;CAD,coronaryarterydisease;CAS,coronaryarterystenosis;DBP,diastolicbloodpressure;eGFR,estimatedglomerularfiltrationrate;FRS,Framinghamriskscore;HDL-C,high-densitylipoproteincholesterol;hypertension,SBP≥ 140mmHgand/ orDBP≥ 90mmHgortreatment;IMT,intima-mediathickness;JALS-ECC,JapanArteriosclerosisLongitudinalStudy-ExistingCohortsCombine riskscore;LDL-C,low-densitylipoproteincholesterol;SBP,systolicbloodpressure;UKPDS,UKProspectiveDiabetesStudy. CAS (Fig. 1A) . CAS was observed in 12 patients (31%)inT1,23patients(59%)inT2and33patients (87%) in T3 according to the UKPDS tertile (Fig.  1B) . Fourteen patients (35%) in T1 had CAS, 20 patients(59%)inT2hadCASand34patients(81%) in T3 had CAS, according to the JALS-ECC tertile (Fig. 1C) .The analyses of trends throughout the tertilesofFRS,UKPDSandJALS-ECCshowedsignificantassociationsbetweeneachriskscoreandthepresence of CAS (P＜0.001 for FRS and UKPDS, and P = 0.001forJALS-ECC).
AUCs for the Risk Scores, Max-IMT and Their Combination
Theareasunderthecurves ( 
Additive Effect of the Max-IMT or Mean IMT on the Risk Score for the Prediction of CAS
Fisher's exact test was performed to assess the effect of the max-IMT or mean IMT measurements onthepresenceofCAS,independentofthecalculated risk scores. For this purpose, the max-IMT, mean IMTandeachriskscorewerecategorizedintotertiles. Fisher's exact test was performed for each risk score three patients were excluded because they had either type1diabetes(n= 3),knownCAD(n = 4),comorbid endocrine disorders (n = 7) or hypertriglyceridemia (n = 1)orwereinapoorgeneralcondition(n = 3).An additional five patients were excluded due to motion artifactsand/orclipartifacts,leaving116patientsfor theanalysis.Amongthepatients,109hadamax-IMT of ≥ 1.1 mm, 36 exhibited ischemic changes on an ECG,24hadapositiveexerciseECGtestand35had aleftventricularwallmotionabnormalityonechocardiography; some patients had two or more of these conditions.Table 1liststhesubjects'baselinecharacteristicsaccording tothepresenceofCAS.Asshown inTable 1,comparedwiththosewithoutstenosis(stenosis(−)group),morepatientswithstenosis(stenosis (＋) group) were older and male and had a longer durationofdiabetes,higherrateofhypertensionand/ or retinopathy, higher mean IMT, higher max-IMT, higher number of carotid plaques, greater common carotid interadventitial diameter, higher FRS, higher UKPDS, higher JALS-ECC and higher frequency of hypertensiveagentuse;differencesintheseparameters betweenthestenosis(＋)andstenosis(−)groupswere significant.TheHDL-Clevels,however,weresignificantlylowerinthestenosis(＋)groupthaninthestenosis(−)group (Table 1) three risk scores. The AUCs for the combination of the max-IMT with each risk score were higher than those for each risk score alone ( Fig. 2 ).Theinclusionofthemax-IMTwassignificantlyassociatedwithadecreaseintheORsofthese Table 2 ). Table 4 shows the results of IDI for each risk scorefollowingtheadditionofeachIMT-relatedvariableforthepresenceofCAS.TheIDIvaluesforFRS, UKPDS and JALS increased by 9.3% (95% CI 3.4-15.3%),6.8%(95%CI2.1-11.5%)and8.7%(95% CI3.2-14.2%),respectively,whenamax-IMTof≥ 1.9 mm as a cut-off point was added to each three risk all three risk scores and the max-IMT were able to predict CAS with moderate accuracy. Second, the combination of a risk score with the max-IMT improved the prediction of CAS detected on CCTA. Finally,themax-IMThadathresholdfortheprediction of CAS when combined with each of the three riskscores.
all, respectively, when a max-IMT of ≥ 1.9 mm as a cut-offpointwasaddedtoeachofthethreeriskscores ( Table 5) .
Discussion
Thisstudyproducedthreemajorfindings.First, . In contrast,MIandsuddendeathareincludedasCAD events in the UKPDS, whereas only acute MI is includedasaCADeventintheJALS-ECC 8, 9) .Both the FRS and UKPDS predict the 10-year risk of events,whileonlythe5-yearriskofeventsispredicted intheJALS-ECC.Furthermore,theFRSandUKPDS weredevelopedinWesterncountries,whiletheJALS-ECC was developed based on Japanese cohorts.The UKPDS is also specialized for type 2 diabetes. We believe that the UKPDS has several advantages over theotherriskscoreswithregardtopatientswithtype 2diabetes,particularlyasitincorporatesinformation regardingglycemiaandthedurationofdiabetesmellitus.Thedurationofdiabeteshasbeenshowntobean independentpredictorofCAS 14, 26) .Therefore,further studies are needed with respect to the associations betweenallthreeoftheseriskscoresandtheincidence ofCASinpatientswithdiabetes.
Despiteextensivestudiesandthedevelopmentof severalriskpredictionmodelsthatincluderiskscores, traditionalCADriskfactorsfailtopredictthedevelopmentofCADinalargenumberofcases(25%to 50%) 10, 11) .Therefore,newstrategiesareneededtodiscriminate patients who would benefit most from intensive primary prevention efforts. Polak et al. showedthatthecombinationoftheFRSandcarotid IMT improves the prediction of cardiovascular disease 15) .Inthatstudy,followingfurtheradditionofan internalcarotidarterymax-IMTof ＞1.5 mminthe original model, the AUC and NRI increased significantlyfrom0.748to0.762and7.3%,respectively 15) . AsimilarresultwasreportedbyYoshidaet al.inthat the AUCs for the prediction of cardiovascular events increased from 0.645 to 0.656 in Japanese patients withtype2diabeteswithanegativehistoryofcardio-vasculardisease 16) .Meanwhile,Irieet al.showedthat the combination of the UKPDS and max-IMT improves the prediction of CAS; the AUC increased from 0.66 to 0.74 in Japanese patients with type 2 diabeteswithoutahistoryofcardiovasculardisease 26) . The present results are comparable to these findings, indicating that the combination of a risk score and max-IMTisusefulforpredictingCASaswellascardiovascularevents.
The present study suggests that the max-IMT modulatestheriskindicatedbytheFRS,UKPDSand JALS-ECC, given that the ORs from the top to the bottomcategorydecreasedfollowingtheinclusionof the max-IMT in the various models. An increased max-IMT was found to be associated with an increasedfrequencyofpatientswithCASamongthose in the lowest and middle tertiles for all three risk Because prospective observational studies using CCTA have shown that the development of obstructive CAD precedes coronary events 2, 21) , identifying patientswithCASisimportantforappropriatemanagementinordertopreventcoronaryeventsinasymptomaticindividuals.Multipleriskmodelsfortheprediction of cardiovascular risk in individual patients havebeendeveloped,andmanyriskscoreshavebeen showntohavetheabilitytopredictfuturecardiovascular outcomes in patients with type 2 diabetes [22] [23] [24] . TheAUCsofriskscoresfordiabetestopredictcoronaryeventshavebeenreportedtorangefrom0.61to 0.80 25) . Several reports have evaluated the relationships between various risk scores and the presence of CAS detected on CCTA [26] [27] [28] . According to ROC curve analyses for the prediction of significant CAD, the AUCforFRSwasfoundtobe0.67inageneralChi-nesepopulationand0.68insymptomaticDutchsub-jects, while the AUC for UKPDS was found to be 0.66inJapanesepatientswithtype2diabeteswithout ahistoryofCAD [26] [27] [28] .Inthecurrentstudy,theAUCs for FRS, UKPDS and JALS-ECC were 0.763, 0.785 and 0.767, respectively. The difference in AUCs according to the ROC curves between each of these studies and the present study may be due to differencesincharacteristicsbetweenthestudysubjects.For example,theseverityofcoronaryriskandtheraceof the study participants differed between these studies. WereservedCCTAforuseinpatientsathighriskfor CADintermsoftherisk-benefitratio,whereasLeeet al. included Chinese subjects who underwent CCTA aspartofageneralhealthcheckup 27) andVersteylenet al.enrolledpatientswithstablechestpain 28) .Although boththepresentstudyandthatbyIrieet al.enrolled Japanesepatientswithtype2diabeteswithnoknown CAD, the present subjects had higher body mass index, SBP and DBP values, a higher prevalence of retinopathy, higher HbA1c and LDL-C levels and lower HDL-C levels than the subjects evaluated by Irieet al. 26) .Thiswouldaccountforthedifferencesin the AUCs on the ROC curve analyses observed betweenthesetwostudies.
To the best of our knowledge, no studies have evaluated the relationship between JALS-ECC and obstructive CAD as determined on CCTA. In the present study, the largest AUC was observed for the UKPDS, followed in order by the JALS-ECC and FRS. This variation in the predictive ability of each riskscoremayberelatedtodifferencesinpatientcharacteristics, length of follow-up, number and type of defined CAD events or measurements of CAD risk factors.Forexample,MI,anginapectorisandsudden between the measurement sites in the Cardiovascular Health Study 31) or Rotterdam Study 32) in the predictionofcardiovasculardisease.Thepredictivevalueof each of the three measurement sites (CCA, ICA or bulb) and all three sites combined was similar 31, 32) . Further studies are therefore needed to compare the predictivevalueofeachmeasurementsiteoftheIMT withrespecttothepredictionofCAS.
Study Limitations
This studyisassociatedwithseverallimitations. First, it was cross-sectional with a relatively small number of subjects, all of whom were Japanese.The numberofpatientswastoosmalltoassessaclinically useful cut-off value. In addition, the study patients were selected based on previously described reasons thatallowedfortheappropriateuseofCCTA.Ideally, CCTA would be performed in all admitted patients. We could not, however, ethically perform CCTA in patients due to associated risks, such as renal failure. Althoughthesesubjectswereasymptomatic,theywere at high risk for cardiovascular disease. Moreover, all patients underwent carotid echography, ECG and echocardiography; however, only 55 received exercise ECG tests. In addition, we excluded subjects with a TG level of ≥ 4.5 mmol/L because we calculated the LDL-C level using the Friedewald equation. These issuesmayhaveintroducedselectionbias.Thepresent dataregardingtheAUCofthemax-IMTforthepredictionofCAS,however,canbeconsideredsimilarto the results of previous studies 12, 13, 26) . Therefore, we believe that the present results are applicable to patientswithtype2diabeteswithalowtomoderate risk of CAS. Second, all participants were Japanese, andnopreviousstudieshaveevaluatedtheefficacyof theFRSforpredictingCASinaJapanesesample.Furthermore,theFRShasbeenreportedtooverestimate theincidenceofcardiovasculardiseaseinotherpopulations 33, 34) .TheFRSandUKPDSscoreswerehigher thantheJALS-ECCscoresinthepresentstudy;however,theFRSandUKPDSexhibitedadiscriminatory accuracysimilartothatoftheJALS-ECCfordetectingCASaccordingtotheAUC.Therefore,theserisk scores may be useful in Japanese individuals. Third, the IMT measurements were obtained by two expert sonographersaspartofroutineclinicalexaminations, which allows for intra-sonographer differences. We defined the max-IMT as the greatest measurable thicknessonbothsidesoftheCCA,bulbusandinternalcarotidartery.Itispossiblethatweunderestimated the max-IMT in patients with advanced atherosclerotic disease and/or an older age. Finally, we did not havedatafortheoutcomesrelatedtoCADinorderto scores. Therefore, these subjects may benefit from additional noninvasive tests, such as measurement of the max-IMT. The addition of max-IMT measurementscanbeusedtoidentifyhigh-risksubjects,especiallythosewithlowriskscores,whoshouldundergo exercise stress testing, single photon emission computed tomography or CCTA and may be managed withintensivelifestylemodificationandmedicaltherapy, particularly aggressive lipid-lowering treatment 29, 30) . Thepresentdataalsosuggestthatthemax-IMThasa threshold for the prediction of CAS in combination witheachofthethreeriskscores,astheprevalenceof CAS clearly increased between the lowest tertile and middletertileandwassimilarbetweenthemiddletertile and highest tertile in the max-IMT category. Moreover, both the NRI and IDI, following the furtheradditionofamax-IMTof≥ 1.9mm,totheoriginalmodelwerehigherthanthoseobservedfollowing thefurtheradditionofthemax-IMTasacontinuous variabletoallthreeriskscores.Unfortunately,wewere unabletoethicallyperformCCTAinpatientswitha max-IMT of ＜1.1 mm for comparison with those with a max-IMT of ≥ 1.1 mm. Further studies are thusneededinordertoclarifythesepoints.TheprevalenceofCASwasactuallyhigherinthemiddletertile than the highest tertile in the max-IMT category in combinationwiththeFRSlowesttertile,theUKPDS lowestandmiddletertilesandtheJALSmiddletertile. Since our study had a cross-sectional design and we excludedpatientswithCAD,wemayhaveunderestimatedtheprevalenceofCASinthehighesttertilein themax-IMTcategory.
Irieet al.showedthatthemax-IMThasahigher AUC than the mean IMT in the prediction of CAS. Intheirstudy,theAUCsforthemax-IMTandmean IMT were 0.73 and 0.65, respectively 26) . Similar resultswereobservedinourpreviousstudy;theAUCs for the max-IMT and mean IMT were 0.711 and 0.581, respectively 14) . Moreover, the inclusion of the max-IMTwassignificantlyassociatedwithadecrease in the ORs of the three risk scores, whereas the decrease in the ORs was modest in the models that included the mean IMT for predicting CAS. Meanwhile, Polak et al. showed that the use of the maxIMToftheinternalcarotidartery,notthemeanIMT of the CCA, significantly improves the classification ofriskofcardiovasculardisease 15) .Inthatstudy,both theNRIandIDIsignificantlyincreasedfollowingthe additionofamax-IMTof≥ 1.9mm,butnotamean IMTof≥ 0.9mm,totheoriginalmodelforallthree risk scores. Taken together, the max-IMT is a more usefulpredictorofCASthanthemeanIMT.Nodifferenceswerefoundinthestrengthoftheassociations determinewhichriskscoresorclinicalpredictorsmay be more predictive of coronary events. The present results should therefore be confirmed in prospective studies with an appropriate sample size and subjects fromvariousethnicgroups.
Conclusion
The FRS, UKPDS, JALS and max-IMT are all usefulvariablesforpredictingCAS.Thecombination ofariskscorewiththemax-IMTimprovesthepredictionofCASincomparisonwiththeriskscorealone. 
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